Sign In
Buy ELOX
$12.05
+0.300 (+2.55%)
At Close: Jun 26, 2026
Eloxx Pharmaceuticals Reports Third Quarter 2020 Financial and Operating Results and Provides Business Update
04:01pm, Thursday, 05'th Nov 2020
Expect to report top line data from our Phase 2 cystic fibrosis clinical trials in the first half of 202 1
Eloxx Announces The Publication of Two Manuscripts on ELX-02 and It's ERSG Library In Two Leading Journals
07:30am, Tuesday, 27'th Oct 2020
A Publication titled: “ELX-02: an investigational read-through agent for the treatment of non sen se mutation-related genetic disease” has been published in the Expert Opinion on Investigational D
Enrollment in the U.S. Phase 2 Clinical Trial in Cystic Fibrosis Has Resumed After Being Paused in Response to the COVID-19 Pandemic
11:30am, Wednesday, 12'th Aug 2020
WALTHAM, Mass., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutic
Eloxx Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results and Provides Business Update
11:30am, Thursday, 06'th Aug 2020
Enrollment in our Phase 2 clinical trial program for ELX-02 in cystic fibrosis has been resumed in Europe and Israel after being temporarily paused due to the COVID-19 pandemicU.S. FDA has granted orp
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
Eloxx Pharmaceuticals Receives U.S. Orphan Drug Designation for ELX-02 for the Treatment of Cystic Fibrosis
11:30am, Tuesday, 04'th Aug 2020
ELX-02 had previously been granted orphan medicinal product designation for the treatment of Cystic Fibrosis by the European Medicines AgencyWALTHAM, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Eloxx Pha
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Eloxx Pharmaceuticals to Present at the 40th Annual Canaccord Genuity Virtual Growth Conference on August 13th, 2020
04:33pm, Tuesday, 28'th Jul 2020
WALTHAM, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutic
Eloxx Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Business Update on August 6, 2020
06:17pm, Tuesday, 21'st Jul 2020
WALTHAM, Mass., July 21, 2020 -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel.
Do Institutions Own Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Shares?
04:37pm, Friday, 17'th Jul 2020
Every investor in Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) should be aware of the most powerful shareholder groups...
Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Pharmacology and Experimental Therapeutics
05:08pm, Wednesday, 15'th Jul 2020
WALTHAM, Mass., July 15, 2020 -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel.
Canaccord Genuity Sticks to Its Buy Rating for Stoke Therapeutics (STOK) - Markets
10:08am, Friday, 26'th Jun 2020
Canaccord Genuity analyst Michelle Gilson reiterated a Buy rating on Stoke Therapeutics (STOK – Research Report) today and set a
NI woman opens up about CF battle and helping others after surviving ICU
07:28pm, Sunday, 21'st Jun 2020
The Newtownabbey woman is giving something back with new clothing brand '65 roses'
Xeris Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
10:09am, Saturday, 20'th Jun 2020
Xeris Pharmaceuticals reports positive topline data for insulin trial. Eloxx restarts cystic fibrosis study. Adamas Pharmaceuticals reports disappointing data f
Eloxx Pharmaceuticals (OTCMKTS:ELOX) Stock Price Up 15.7%
05:50am, Saturday, 20'th Jun 2020
Shares of Eloxx Pharmaceuticals (OTCMKTS:ELOX) shot up 15.7% during mid-day trading on Thursday . The stock traded as high as $4.02 and last traded at $3.53, 1,051,386 shares traded hands during mid-d
